23 employees
Mecwins uses its technology to produce sensitive immunoassays for oncology, cardiovascular disease, and infectious diseases.
2008
$5.4M
from 2 investors over 2 rounds
Mecwins raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)
Mecwins raised $5.4M on June 5, 2014
Investors: CRB Inverbío SGEIC